цялостни стратегии


на лекарства


на лекарства
+359 2 421 0829; +359 2 442 6262

Oklys® awarded “Product of the Year” by the Bulgaria Pharmaceutical union

The prestigious prize is for technological innovation of OTC product and was presented to the team of BestaMed within the Bulgarian Pharmaceutical Days 2021

The latest medicinal product of BestaMed – Oklys® was selected as “Product of the Year” in the category “OTC medicinal product for technological innovation for the dosage form” for 2021. The award was presented to the team of BestaMed on June 25th as part of the annual forum Bulgarian Pharmaceutical Days 2021 in Borovets.

A special commission determined Oklys® as the winner in its category due to its impeccable nomination of a unique drug on Bulgarian market, which thanks to the Ibuprofen L-arginine Combination in granules for oral suspension in sachet enhance fast and continuous pain relief.

Oklys® innovative formula makes it the only one of its kind in Bulgaria, an analgesic that relieves immediately and guarantees a quick and lasting analgesic effect. Oklys® has proven its effectiveness and affects pain in muscle and bone diseases and inflammation, headache, toothache, postoperative pain, primary dysmenorrhea, rheumatoid arthritis and juvenile rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and other acute or chronic rheumatic processes. Anesthetizes soft tissues in sprains and strains, has a beneficial effect on pharyngitis, tonsillitis, ear infections.

“On behalf of the entire team of our talented and responsibly developing pharmaceutical company – BestaMed – I am honored to receive the Oklys® award against decent and strong competition,” said in his speech Georgi Dimitrov – Regional Sales Manager in BestaMed Bulgaria, who received the prize.

“Since BestaMed was founded, during the 10 years of our activity, we have managed with great effort and professionalism to establish the company as a sustainable and reliable partner in healthcare. In 2015 we began to implement our long-term strategy to expand the portfolio of medicinal products under our own brand. We are happy that you appreciated the work, perseverance and the result we managed to achieve,” stated Georgi Dimitrov.

Dimitrov stated that BestaMed will continue to invest in innovative solutions, creating products with the spirit of Oklys® – drugs without analogue in Bulgaria in the name of human health and quality of life. “Because our continuous goal is to provide strategic solutions in the service of you – our partners and patients,” concluded Dimitrov.

Learn more about Oklys® here.